EVIDENCE LIBRARY
Pediatric Liver-Injury Review Listed Potential CYP Interactions Separately From Causality Scores
A retrospective ICU study evaluated suspected liver injury and medication combinations. A listed midazolam interaction did not itself prove that the drug caused liver injury.
A retrospective ICU study evaluated suspected liver injury and medication combinations. A listed midazolam interaction did not itself prove that the drug caused liver injury.
The two assessments
The investigators screened records for possible drug-induced liver injury and applied an updated RUCAM assessment. They also identified combinations potentially affecting CYP metabolism.
Midazolam-containing pairs and diazepam with omeprazole appeared in the combination analysis. These were not interchangeable with the highest-ranked suspected causes of liver injury.
A potential mechanism is not an event
Co-prescribing two substrates or interacting medicines does not establish a clinically important concentration change in every patient. A causality score likewise depends on the available timeline and exclusion of alternatives.
The study was retrospective and single-center, and adult-derived injury thresholds were used for pediatric screening. Critical illness itself can affect liver tests. The paper supports separating exposure, predicted interaction, biochemical injury, and causal assessment, rather than treating a benzodiazepine’s appearance in a table as proof of hepatotoxicity.
Source paper
Original analysis of the supplied journal article, identified as PMC8721278.